A method includes obtaining monitoring data recorded by first and second devices, the first and second devices being attached to the subject at different first and second sties, respectively. The monitoring data comprises signals associated with at least one physiological parameter of the subject. The method also includes extracting one or more features of the signals recorded by the first and second devices during a transitionary period when the first and second devices simultaneously monitor the at least one physiological parameter of the subject. The method further includes generating at least one correlation parameter by analyzing the extracted features of the signals recorded by the first and second devices for at least a portion of the transitionary period, the at least one correlation parameter when applied to signals recorded by the second device at least partially compensating for relative changes in signals recorded by the first and second devices.

A blood glucose tracking system and method measures emitted microwave energy transmitted to and accepted by blood vessels in a desired target area of a patient in order to determine, in real time and in vivo, appropriate blood glucose levels. A measurement unit comprises a transmitter operatively connected to an antenna to deliver energy towards appropriate subcutaneous blood vessels. The measurement unit determines an accepted energy power value in the blood vessels associated with the desired target area. This measurement energy power value is compared with a calibration value, and the difference is used to determine a resultant blood glucose value. The determined blood glucose value may further be acclimatized using additional sensed values compensating for biological and ambient factors relevant to the patient. The final determined blood glucose value can be displayed for reading and/or transmitted and stored for recording for further reference.

Devices and methods are provided for continuous measurement of an analyte concentration. The device can include a sensor having a plurality of sensor elements, each having at least one characteristic that is different from other sensor(s) of the device. In some embodiments, the plurality of sensor elements are each tuned to measure a different range of analyte concentration, thereby providing the device with the capability of achieving a substantially consistent level of measurement accuracy across a physiologically relevant range. In other embodiments, the device includes a plurality of sensor elements each tuned to measure during different time periods after insertion or implantation, thereby providing the sensor with the capability to continuously and accurately measure analyte concentrations across a wide range of time periods. For example, a sensor system 180 is provided having a first working electrode 150 comprising a first sensor element 102 and a second working electrode 160 comprising a second sensor element 104, and a reference electrode 108 for providing a reference value for measuring the working electrode potential of the sensor elements 102, 104.

The present invention relates to assessing a psychophysiological responsiveness or non-responsiveness of a subject. A device (10) for assessing a psychophysiological responsiveness of a subject is presented, the device comprising a stimulus unit (11) for providing an electrical stimulus via a first and a second electrode (21, 22) to a skin (100) of the subject; a sensing unit (12) for acquiring an impedance signal (15) indicative of an impedance between the first and the second electrode in response to said electrical stimulus; and an analysis unit (13) adapted to identify an electrical double-layer based on the impedance signal acquired in response to the electrical stimulus and to determine a psychophysiological responsiveness of the subject based on the identified electrical double-layer. It has been found that identifying the presence or absence of an electrical double-layer based on the impedance signal acquired in response to the electrical stimulus can serve as a reliable indicator whether the subject is in a responsive or nonresponsive psychophysiological state. Further, a corresponding method, computer program and system (1) are presented.

Among others, the present invention provides apparatus comprising two micro-devices each fabricated by the method comprising: the first step of depositing a first material onto a substrate; the second step of depositing a second material onto the first material and then patterning the second material with a microelectronic technology or process; and repeating the second step at least once with a material that can be the same as or different from the first or second material. The micro-devices can pierce through the membrane of a circulating tumor cell and can move in different direction.

Systems and methods are disclosed that provide smart alerts to users, e.g., alerts to users about diabetic states that are only provided when it makes sense to do so, e.g., when the system can predict or estimate that the user is not already cognitively aware of their current condition, e.g., particularly where the current condition is a diabetic state warranting attention. In this way, the alert or alarm is personalized and made particularly effective for that user. Such systems and methods still alert the user when action is necessary, e.g., a bolus or temporary basal rate change, or provide a response to a missed bolus or a need for correction, but do not alert when action is unnecessary, e.g., if the user is already estimated or predicted to be cognitively aware of the diabetic state warranting attention, or if corrective action was already taken.

The disclosed invention includes sweat sensing devices configured to periodically measure sweat conductivity and galvanic skin response, devices to measure volumetric sweat flow rate, and devices that combine the three functions. The disclosure further includes methods for using a device configured to perform periodic sweat conductivity measurements, galvanic skin response measurements, and volumetric sweat rate measurements so that each sensor modality informs composite estimates of sweat onset, sweat cessation, sweat ion concentration, and sweat rate. The method uses those measurements to inform other sweat sensing device functions, such as determining the existence of a physiological condition, or performing measurements of concentrations, ratios, and trends of sweat analytes.

An exercise assistance device includes a biological information acquisition unit, a storage unit, an exercise menu setting unit, and an exercise menu presentation unit. The biological information acquisition unit acquires, from a biosensor that measures a measurement target substance contained in a secretion from a living body, biological information indicating a result of such measurement by the biosensor. The storage unit stores the biological information. The exercise menu setting unit sets an exercise menu based on the biological information stored in the storage unit. The exercise menu presentation unit presents the exercise menu set by the exercise menu setting unit.

The present invention is directed to a wearable system wherein elements of the system, including various sensors adapted to detect biometric and other data and/or to deliver drugs, are positioned proximal to, on the ear or in the ear canal of a person. In embodiments of the invention, elements of the system are positioned on the ear or in the ear canal for extended periods of time. For example, an element of the system may be positioned on the tympanic membrane of a user and left there overnight, for multiple days, months, or years. Because of the position and longevity of the system elements in the ear canal, the present invention has many advantages over prior wearable biometric and drug delivery devices.

A device for a user-actuated mixing mechanism includes a cartridge with a dry reagent compartment, a liquid reservoir, and a fluidic barrier. The fluidic barrier is capable of separating the dry reagent compartment from the liquid reservoir. The dry reagent compartment may contain at least one lyophilized enzyme and the liquid reservoir may contain at least one liquid reagent. The liquid reservoir is capable of receiving a target analyte from secretions of a test subject using the device. When the fluidic barrier is removed from the cartridge, the dry reagent compartment is in contact with the liquid reservoir such that the lyophilized enzyme is capable of reacting with the target analyte from the test subject.